{
  "trial_id": "NCT01852799",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Man or woman aged 18 to 65 years old",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Newly diagnosed MM patients scheduled for vincristine, adriamycin and dexamethasone standard therapy",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Stage II/III with skeletal involvement",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Life expectancy > 3 months",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Measurable disease (serum M-protein level >10.0 g/L or urinary M-protein excretion > 1 g/24 hours)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Bone marrow plasmacytosis of > 30% by bone marrow aspirate and/or biopsy",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Serum free light chains (by the Freelite test) > 2 X the upper limit of normal",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Performance status (PS) of ECOG \u22642.0",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Platelets count\u226550\u00d710^9 cells /L",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Absolute neutrophil count (ANC)\u22650.75\u00d710^9 cells /L",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Adequate hepatic function (ALT \u2264 2.5 \u00d7 upper limit of normal)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Adequate renal function (creatinine clearance >30 ml /min)",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Non-secretory MM, unless measurable lesions on CT, MRI and/or PET",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Peripheral neuropathy or neuropathy pain grade 2 or high as defined by NCI CTCAE Version 3",
      "label": "triggers",
      "evidence": "unknown"
    }
  ],
  "notes": "The patient has a confirmed diagnosis of Paget's Disease of Bone and will be treated with Bisphosphonate. The patient meets most inclusion criteria but has peripheral neuropathy, which is an exclusion criterion.",
  "_meta": {
    "topic_id": "40",
    "trial_id": "NCT01852799",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}